The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes by Dehdari, L. & Dehdari, T.
RESEARCH Open Access
The determinants of anti-diabetic
medication adherence based on the
experiences of patients with type 2
diabetes
Laleh Dehdari1 and Tahereh Dehdari2*
Abstract
Background: The purpose of this study is to explain the experiences of patients with type 2 diabetes (T2DM) about
medication adherence.
Method: A qualitative content analysis study was conducted at the Institute of Endocrinology and Metabolism
Research and Training Center of Firoozgar Academic Hospital, affiliated to Iran University of Medical Sciences in
Tehran, Iran during April–June 2017. Twenty-six semi-structured in-depth interviews were conducted with diabetic
patients and their families. The participants were asked about their experiences of medication adherence. After the
first round of the interviews, content analysis of data started and continued up to the data saturation.
Results: Four main themes including perceived barriers (with 6 subthemes including inadequate knowledge,
situational influences, inadequate perceived threat about diabetes, treatment characteristics, personality traits and
medication cost), perceived social support (with 3 subthemes including family, doctor and community supports),
medication beliefs (with 3 subthemes including belief in the effectiveness of treatment, belief in the more
effectiveness of complementary therapies than medication use and prioritizing the use of the pills instead of the
insulin injection) and cues to action (with 2 subthemes including internal and external cues to action) emerged as
the experiences of the participants in terms of anti-diabetic medications adherence which should be considered in
developing medication adherence interventions for the patients with T2DM.
Conclusion: The patients with T2DM had more barriers for regular drugs consumption. They had incorrect beliefs
about anti-diabetic drugs. In addition, they were in need of abroad support community, surroundings and also
health professionals. Health systems should consider medication adherence training to be added to the treatment
protocols of the diabetic patients.
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Background
Type 2 Diabetes is a growing public health issue in Iran.
Approximately 24% of Iranian adults above 40 years old
suffer from Type 2 diabetes. The risk of the disease in
Iranian women is 1.7% greater than men [1].
Patients with T2DM need to receive continuous medical
care besides self-management and lifestyle modification
education to prevent and reduce the risk of acute and
long-term complications. Drug therapy is an essential
element of diabetes care [2]. Successful glycemic control
in type 2 diabetes requires the effective use of the
prescribed medicines over time [3]. Several different
pharmacological agents such as Metformin, Glinides,
α-Glucosidase inhibitors, Insulin, Thiazolidinediones and
Sulfonylureas are prescribed for glycemic control in pa-
tients with T2DM [4]. Although these agents can substan-
tially reduce the diabetes-related morbidity and mortality,
the extent of treatment benefits may be limited by a
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poorer prescribed medication adherence [3]. Non- adher-
ence to chronic diseases has been described as taking <
80% of the prescribed treatment. Adherence to diabetes
treatment has been reported to be suboptimal ranging
from 23 to 77% [5]. Donnan et al. showed that one in
three people with Type 2 diabetes had suitable adherence
to prescribed oral hypoglycaemic medications [6]. The
rate of non-adherence among Iranian patients with
T2DM for using metformin, glyburide and insulin was
39.7, 35.3 and 28.8% respectively [7, 8]. In diabetic pa-
tients, poor adherence to medications was associated
with a higher HbA1C profile; more manifestation of
diabetes-related complications such as retinopathy,
neuropathy, and nephropathy; poor quality of life;
greater healthcare costs; more prior primary care con-
tacts and higher morbidity [7, 9, 10].
Poor medication adherence among people with dia-
betes is a complex behavior which can be caused by
many factors such as being too busy; travelling; skipped
meals; stress/emotional problems; public embarrass-
ment; depression; medication cost; memory; knowledge,
attitudes and beliefs about diabetes; worrying about
side-effects of diabetes medicines; social support; inter-
action with health care providers; complexity of medica-
tion regimen; duration of the illness; concern about the
negative effects of medicines and the presence of gluc-
ometer at home [8, 11–14]. However, additional informa-
tion regarding determinant factors that influence
medication adherence is required to develop tailored and
effective interventions to promote medication adherence
in patients with T2DM [15]. Therefore, given the lack of a
comprehensive research on adherence-related factors
among patients with T2DM, the objective of the present
study was to explore the experiences of patients with
T2DM in terms of medication adherence using a qualita-
tive content analysis design.
Methods
Design
In this study, a qualitative content analysis design (con-
ventional method) was used to analyze the experiences
of Iranian patients with T2DM regarding the prescribed
medication adherence.
Setting and study participants
In the present study, purposive sampling (those who
consumed anti- diabetes medications for at least one
year and have not diabetes-related complications such as
retinopathy, neuropathy, and nephropathy were included
in the study) was used to recruit participants from the
Institute of Endocrinology and Metabolism Research
and Training Center of Firoozgar Academic Hospital, af-
filiated to Iran University of Medical Sciences in Tehran,
Iran during April–June 2017. In this study, inclusion
criteria were history of diabetes and blood glucose–con-
trolling medications consumption at least for one year,
not having diabetes-related complications such as retin-
opathy, neuropathy, and nephropathy, agreement to par-
ticipate in study and their willingness to share and
transfer direct and indirect experiences about the medi-
cation adherence. Exclusion criteria were defined as at
each stage of the interview, those participants who did
not wish to continue the interview could be excluded. In
the study, no participant was excluded from the study.
Data collection
Data saturation (i.e. when no new information is discov-
ered in the data analysis) occurred by conducting 22 inter-
views with patients and 4 with their families. All
interviews were recorded via audiotapes and transcribed
verbatim. On average, each interview lasted approximately
between 20 and 25min. The interviews were conducted in
a privacy room at the Institute of Endocrinology and Me-
tabolism Research and Training Center of Firoozgar Aca-
demic Hospital. The decision about determining the time
of conducting the interviews was made with the partici-
pants’ consent. Family members and the patients were
interviewed separately. Interview topics included the par-
ticipants’ and their family’s experiences of medication ad-
herence, and influencing factors involved in irregular
prescribed medication use. Sampling continued until sat-
uration was reached. Demographic characteristics of the
study participants included age, sex, marital status, occu-
pation status and education level which were collected by
means of a self-administered questionnaire.
Data analysis
The interviews were recorded and next transcribed ver-
batim. The procedures involved in content analysis con-
sisted of careful reviewing of the transcripts for four
times. Upon reviewing the transcripts, a general impres-
sion was obtained. Then, based on the participants’ and
their family members’ statements meaning units and
their coding were conducted. Two researchers identified
the initial codes in the data. Later, their coding was in-
vestigated for the degree of go-togetherness. Through
further reviewing of the transcripts, initial codes were
merged to account for the major themes in the data. In
fact, through this data reduction procedure text was re-
duced to codes and themes. The emerging categories
were constantly compared across and within the inter-
views to establish and refine categories which reflected
the nuances of the data. Data collection proceeded in
this way until saturation was achieved [16].
Rigor
Since the participants refereed to the clinic for visit
endocrinologist regularly several times in a year, the
Dehdari and Dehdari Archives of Public Health           (2019) 77:21 Page 2 of 9
researchers had sufficient time to communicate and
build trust and rapport with them. Prolonged engage-
ment with the participants helped to achieve in-depth
data collection. Maximum-variation sampling was
employed based on the participants’ age, gender, educa-
tion level and number of years with diabetes. To ensure
that the analysis reflected the participants’ experiences
accurately, member check was carried out with 11 par-
ticipants and 2 of their family members. By using the ex-
ternal check method, two research advisors reviewed a
random selection of more than 50% of the transcripts
and the codes [17].
Results
Twenty-two participants and four members of their fam-
ilies were interviewed. The demographic characteristics
of the study participants are presented in Table 1. After
data analysis, four main themes were identified: (a) per-
ceived barriers, (b) medication beliefs, c) cues to action
and d) perceived social support. Each of the subthemes
was next divided into several other subthemes (Table 2).
Themes
Perceived barriers Perceived barriers, with six subthemes
including inadequate knowledge, situational influences, in-
adequate perceived threat, treatment characteristics, per-
sonality traits and medication cost were identified as one of
the variables that influenced the medication adherence
among the participants.
From the participants’ point of view, high cost of
anti-diabetic medication may decrease the patients’
medication adherence. Expensive insulin, doctor’s visit
fees and blood glucose test strips as well as the lack of
insurance were factors that greatly affected the patients’
compliance in their drug regimens.
“There are lots of costs for a diabetic patient. He/she
needs drugs. He/she needs insulin. Doctor visits or
counseling sessions is very expensive! Access to drugs is
very hard. Each time I pay about 13 or 14 US Dollars
for the drugs. Some cannot buy! They do not have
insurance or income. Although I can buy the drugs,
sometimes it is hard for me to buy them. There should
be a center to support us for buying the drugs”
(A 61-year-old female)
“Glucose monitor tests strips is expensive. My nephews
buy it for me. Glucometer is also very expensive.
Because of that many do not continually check their
blood glucose” (A 59-year-old female)
Apparently such individual barriers inhibiting the regular
medicines use included treatment regimen characteristics.
In this category, factors such as high number of prescribed
medications; taking medications several times a day; worry-
ing about side-effects of diabetes medicines; long period of
treatment and increasing the medications dose over time
may affect the patients, medication adherence.
“Many are afraid of the side-effects of pills or insulin.
They say it may affect kidneys. Also, pills may decrease
the weight. I, for example, lost 19 kilos!” (A 50-year-old
female)
“It’s overwhelming for me! Because I have many pills,
and I have to eat them for several consecutive years!
Doctor increases the pills each year. Its doses increase
each year. It has increased from one to three. The
number is boring!” (A 63-year-old male)
Some participants and their families stated that four
personality traits including being not responsible, no re-
spect for yourself and others, attracting pity and attention
of the family and anxiety and restlessness may influence
on reducing the participants’ medication adherence.
“If somebody cares and be responsible, he/she eats his/her
drugs. Similar to other foods and plans, the time of having
drugs should be set. Some patients do not care about what
might happen to them” (A 55-year-old female)
“Patients should always keep the drugs with
themselves. Anybody who respects him/herself, loving
Table 1 Descriptive statistics of the participants’ characteristics
(n = 22)











≤ 12 th grade 19 86.4




Household duties 11 50
The number of years of diabetes 9.30 7.40
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bodies and his/her health, consumes the drug orderly.
Some patients stimulate others’ sense of pity to receive
more attention! So, they don’t have their drugs to
attract the attention of others” (A 30-year-old member
of one female patients’ family).
“Stressful patients and those who suffer from
depression and anxiety are more likely not to eat their
drugs!” (A 63-year-old male)
Table 2 Categorization of Themes and Subthemes
I. Perceived barriers to medication adherence
A. Medication cost 1. High cost of insulin
2. High doctor visits fees
3. High cost of glucose monitor
test strips
4. High cost of psychological consulting
classes
B. Treatment characteristics 1. High number of prescribed
medications
2. Taking medications several times
a day
3. Worrying about the side-effects
of diabetes medicines
4. Long period of treatment
5. Increasing the medication dose
over time
C. Personality traits 1. Not responsible
2. No respect for oneself and others
3. Attracting the pity and attention
of family
4. Anxiety and restlessness






7. A gap between buying medications
again
8. Irregular meals
E. Inadequate knowledge 1. Lack of knowledge about diabetes
2. Lack of knowledge about the
effectiveness of medication treatments
for the control of diabetes
F. Inadequate perceived
threat about diabetes
1. Not accepting the diabetes as a
disease
2. Not taking the diabetes seriously
II. Perceived social support
A. Family support 1. Reminding the time of taking
medications
2. Preparing the medicines
3. Recalling the complications of
diabetes
4. Helping to follow-up the disease
5. Understanding the patient
6. Helping with insulin injection
B. Doctor support 1. Eliminating the patient’s fear of
insulin
2. Being highly responsible for the
control of diabetes
3. Being able of correct diagnosis
4. Giving morale to the patient
5. Spending time and responding
patient’s questions
6. Appropriate behavior with the patient
7. Encouraging the patient to take
regular medication
8. Informing about the complications
of the irregular use of the medications
9. Describing the relationship between
the medication and disease
10. Writing multiple prescriptions
with more medication simultaneously
Table 2 Categorization of Themes and Subthemes (Continued)
C. Community support 1. Giving information through mass
media
2. Supporting to provide the
medications
3. Increasing the insurance coverage
III. Medication beliefs
A. Belief in the effectiveness
of treatment
1. Belief in controlling diabetes by
regular medication use
2. Belief in the effectiveness of taking
the pills for controlling the blood
glucose
3. Belief in the effectiveness of insulin
injection than the pills use in
controlling blood glucose




1. Belief in the effectiveness of exercise
than medication use in controlling the
level of blood glucose
2. Belief in the effectiveness of having
proper nutrition than insulin use in
controlling the level of blood glucose
3. Belief in the effectiveness of herbal
medications than modern medications
in controlling the level of blood glucose
C. Prioritizing the use of
the pills instead of insulin
injection
1. Having pills being easier than the
insulin injection
2. Pills being cheaper than insulin
3. Fear of needle and insulin injection
4. Difficulty with insulin injection
5. Decreasing morale due to insulin
injection
6. More negative social stigma to
insulin use
7. Existing difficult cconditions for
keeping insulin outdoors
8. Negative family insight about the
insulin injection
9. Feelings of disease progression
following the insulin injection
10. Having good feeling about the use
of the pills instead of insulin injection
11. Predicting death following the
insulin injection
12. Appearing diabetes complications
(such as kidney loss) following the
insulin injection
IV. Cues to action
A. Internal cues 1. Habit of taking medication
2. Fear of diabetes-related
complications
B. External cues 1. Setting the alarm to remind the
time of medications use
2. Presence of medication in front
of the eyes
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Many participants, both male and female, seemed to
be strongly influenced by situational influences for regu-
lar use of their medications. Being at a party, traveling,
the necessity to take the drugs early morning, being out-
doors, watching TV, go shopping, the gap between buy-
ing drugs again and removing one of the meals were
situational contexts which might interfere with the med-
ications adherence among the participants.
“When on a trip or at a party, my father does not eat
his pills. He intentionally does it. I do not know why!
Diabetic patients are like that. He does not like to eat
pills outside. He feels exhausted by eating it. It makes
no difference for them” (A 25-year-old member of one
male patients’ family)
“I get up late! I can’t get up early! I feel dizzy. If getting
up late, I forget to eat my pills or inject insulin. In
fact, irregularity of food meals causes irregularity in
having the pills. Eating pills with empty stomach
bothers me!” (A 56-year-old female)
“One time I forgot to take my insulin out with myself
and forgot to inject it. Being outdoors for shopping or
any other reason causes the consumption disorder”
(A 62-year-old female)
“The interval between buying the drugs and getting the
renewed prescription from physician causes delay and
stops in using my pills. It has been one week that I do
not have the blood glucose pill. Now, I’ve come to get
the prescription. I did not have time to come within
the last week! ”(A 59-year-old female)
Also, the participants in this study showed insufficient
knowledge about diabetes and benefits of glucose-lowering
medication for its control.
“Lack of information about the illness causes
irregular use of the drugs. Most of the patients who
do not have enough information about the benefits
of insulin or the pill do not like to eat or inject it”
(A 50-year-old female)
Subjects identified inadequate perceived threat as a
barrier for the regular drugs use. They stated that some
of diabetic patients do not accept diabetes as a disease
and do not take diabetes seriously.
“Due to lack of surface manifestations at early stages
of diabetes, patients do not take it seriously. Especially,
they do not eat drugs at early stages of diagnosis” (A
38-year-old member of one female’s patient’s family)
“I did not take seriously the first years of diabetes. I
did not consider it as a disease. As my glucose
lowered, I thought I had cured completely. Then, when
I found its side-effects, I tried to use the pills orderly”
(A 56-year-old female)
Perceived social support Acquiring support of family,
doctor and community was very important for many pa-
tients because they helped in the treatment adherence
and their illness control. The participants frequently in-
dicated that families should support patients by remind-
ing the time of taking medications to patients, preparing
the medicines, recalling the complications of diabetes,
helping to follow-up the disease, understanding the pa-
tient and helping with insulin injection. Also, they stated
that doctors should reduce the patient’s fear of insulin,
be highly responsible regarding diabetes control, have
the ability of correct diagnosis, give morale to the pa-
tient, spend time and respond to patient questions, have
appropriate behavior with the patient, encourage the pa-
tient to take regular medication, inform about the com-
plications of the irregular use of medications, describe
the relationship between medication and disease and
write multiple prescriptions with more medication sim-
ultaneously. Also, giving information through mass
media, support to provide the medications and increas-
ing the insurance coverage were among the patients’ ex-
pected supports of their community.
“Family should regularly remind the illness side-effects,
orderly use of pills and drugs. They should care about
the patient. They can also help in providing the drugs.
The family should aid and understand the patient”
(A 59-year-old female)
“My physician writes two prescriptions for me so I
won’t be bothered every six months that I refer. By two
prescriptions, I can buy drugs for three months. It’s
great!” (A 50-year-old female)
“It is good if my father refers to physician once in a
month. He feels he should listen to his physician who
tells him if he does not observe, the illness may progress.
The physician must inform his/her patient about the
illness and its side-effects. In fact, my father irregularly
has his drugs if not taking him to physician irregularly”
(A 42-year-old member of one male patients’ family)
Dehdari and Dehdari Archives of Public Health           (2019) 77:21 Page 5 of 9
“The physician should support patients during the
illness process. He/she should be good-tempered and
communicates well with the patient. Strengthening the
patients’ morale by the physician is very important.
He/she should emphasize on the orderly use of the
drugs. He/she should talk calmly. These mean the
needed support!” (A 63-year-old female).
“The society and media should inform people about
the prevention. During the education time and career,
they should be instructed. Radio, TV and the
newspapers should inform about diabetes and its
side-effects. Also, insulin and glucose monitor test
strips are expensive. The government should support
by increasing the insurance coverage” (A 58-year-
old male)
Medication beliefs Medication beliefs with three sub-
themes were identified as an influencing variable in the
treatment adherence among this group. One of the sub-
themes was that the participants believed that anti-dia-
betic drugs does not affect the blood glucose control.
Those participants with more negative beliefs about the
treatment had more attempt in the medication use.
“My father says he won’t get healed. I have diabetes. It
makes no difference! To eat or not to eat the drugs
does not affect diabetes!” (A 25-year-old member of
one male patients’ family)
“I used pills for 8 years. Now, it has been two years that
I use insulin. Using pills did not help me! I felt dizzy!
When using insulin, it makes me feel better. But I do not
know if it has any effect or not!” (A 65-year-old female)
The second subtheme was that the participants believed
that complementary therapies (e.g. healthy diet, physical ac-
tivity and distillates and herbal drugs consumption) have
more effectiveness than the anti-diabetic medications use.
“Some prefer to eat diet foods so they do not need
using pills. Having a food diet is more effective than
pills” (A 49-year-old female)
“First I have to accept that I have diabetes. Then, I
must have regimen and exercise. Last, drugs are
effective” (A 51-year-old female)
“The traditional medicine doctor has given me some
herbal capsules that I use. Distillates and herbal drugs
are better than chemical drugs. I believe in them more
than the pills” (A 49-year-old female).
The third subtheme was that the participants preferred
pills than the insulin injection. They have good feeling
about the use of the pills. They do not have positive be-
liefs about the insulin and also it injection. From the
viewpoints of some participants, eating pill is easier than
the insulin injection. In addition, pill is considered as
cheaper than the insulin. Some of the participants told
that there was negative social stigma to insulin use in
the family and community. They told that their family
and community had negative insights about the insulin
injection. They did not like to inject insulin in any situ-
ation, because they met with other people’s feelings of
compassion. Some of the participants believed that the
injection of insulin and its storage and conditions for
keeping it outdoors was very difficult; they believed that
if doctor prescribed insulin for them, it meant their dis-
ease had progressed and following the insulin injection
diabetes complications (such as kidney loss) and ultim-
ately death would appear.
“I do not like to inject insulin. If using it, I feel my
disease is progressing and I have not controlled it by
the pills. Any way it is ampoule! Pills are not bothering
than seeing the injection. Having an ampoule in my
hands after each meal is agonizing for my children. It
bothers me as well!”(A 56-year-old female)
“Carrying insulin on trips is difficult! It is hard to
inject insulin in public! You should go to another room
and inject there. Further, it is hard for me to learn
how to inject!”(A 60-year-old male)
“Pills are cheaper, but insulin is expensive. I’m afraid
of insulin, inflation and needle! Most of the patients
say that injecting insulin shows the ultimate of the
disease! These people have given a positive response to
death! They wish for a relaxing death, so they try not
to inject insulin” (A 57-year-old female)
Cues to action The majority of the study participants
highlighted the importance of internal and external cues
to medication adherence. The habit of taking medication
and fear of diabetes-related complications were internal
cues to regular prescribed drug using among the partici-
pants. In addition, setting the alarm to remind the time
of medications use and the presence of medication in
front of the eyes were reported as external cues to medi-
cation adherence by the participants.
Dehdari and Dehdari Archives of Public Health           (2019) 77:21 Page 6 of 9
“Sometimes my father slams and does not eat his pills
for some days. But he again fears and eats. The fear of
foot scars, retinal hemorrhage or harm to kidneys can
be as flips for the orderly use of the drugs. Those who
have experienced the diabetes side-effects should be
shown to others, so they use their drugs well” (A 25-
year-old member of one male patients’ family)
“Since I have been using 9 pills per day for 12 years, I
do not forget it like eating food. I am used to having
it” (A 57-year-old male)
“I should keep my drugs in front of my eyes. Some set
the alarm clock to remind them of eating the drugs”
(A 60-year-old male)
“My wife calls me and reminds me of using the pills! ”
(A 53-year-old female).
Discussion
The obtained results provided reputable information on
the participants’ experiences of medication adherence.
There appears to be several factors that affected the
regular prescribed pharmacologic agents among a sam-
ple of Iranian patients with T2DM. Understanding these
factors is required to develop tailored and effective ef-
forts aimed at increasing the medication adherence
among the patients with T2DM.
Perceived barriers with six subthemes including inad-
equate knowledge, situational influences, inadequate
perceived threat, treatment characteristics, personality
traits and medication cost are known as one of the par-
ticipants’ experiences regarding the treatment adherence.
The finding is consistent with those of Rubin who
showed that the patient’s comprehension of the pharma-
cologic therapy regimen and its benefits, medication ad-
verse effects, medication cost, regimen complexity and
the patient’s emotional well-being may all influence the
treatment adherence among the patients with T2DM
[18]. Jeragh-Alhaddad et al. also showed that the lack of
education/awareness about diabetes/medications and be-
liefs about medicines/diabetes can reduce the diabetic
patients’ medication adherence [19]. Bailey and Kodack
further reported that the poor adherence can be contrib-
uted to complex dosing regimens [20]. Considering the
fact that almost majority of the barriers are resolvable by
educating patients, courses of medication adherence
should be developed and added in educational protocols
for the diabetic patients. The content of the courses may
consist of explanation about diabetes disease, diabetes’s
acute and long-term complications, anti-diabetic drugs,
its effectiveness and side-effects, the importance of regu-
lar medication use for the control of blood glucose level,
simplifying the medication schedule, increasing active
involvement and accountability of the patients in the
process of medication use management effectively and
helping the patient to overcome the medication ad-
herence obstacles. For increasing the effectiveness of
educational courses, using theory-based conseptual
frameworks is suggested [21, 22].
In our study, some of the participants reported that
medication beliefs may influence the treatment adher-
ence. Some others believed that anti-diabetic drugs had
no effect on diabetes outcomes. Almost a quarter of the
participants (24%) perceived glucose-lowering medica-
tion as harmful chemicals which could have devastating
effects on one’s health. Therefore, they preferred the use
of complementary therapies such as herbs than medica-
tion. In addition, some of the participants stated that
they had good feelings about the use of the pills such as
Metformin, Glibenclamide and so on than injecting in-
sulin. From their perspective, the pills were cheaper, eas-
ier to use and had less social stigma. Also, they
mentioned that the injection of insulin and its storage
was very difficult; their families had negative insights
about the insulin injection; they believed that if doctor
prescribed insulin for them, it meant their disease had
progressed and following the insulin injection diabetes
complications (such as kidney loss) would appear. This
finding is consistent with the previous studies indicating
that negative medication concerns could act as a barrier
in the medication adherence [20, 23–26]. For example,
Aflakseir showed that medication beliefs, such as con-
cerns about the negative effects of anti-diabetic medi-
cines, have an important role in poor adherence among
diabetic patients [13]. Healthcare providers should
identify patients’ perspective on medication beliefs and
provide more effective information to modify miscon-
ceptions about the anti-diabetic medicines.
The authors also found evidence of poor compliance
among the patients with low social support. In our
study, family, doctor and community were three import-
ant sources of support for the patients regarding the
medication adherence. The finding is consistent with
those of other studies which highlighted the role of so-
cial support in adherence to diabetes treatment regimens
[19, 27, 28]. As an example, Tiv et al. found that diabetic
patients need family or social support, medical support,
information on treatment and follow-up by a specialist
for adherence to prescribed medications [27]. It’s worth
mentioning that the study participants stated that good
interaction of doctors with patients was a form of sup-
port. They expected that their doctors beside providing
necessary information regarding diabetes, its
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consequences and the effectiveness of anti-diabetic
medication get along well with the patients. In line with
our findings, Abu Hassan et al. reported that doctors’
practical and emotional supports may help diabetic pa-
tients to accept insulin therapy [29]. This finding em-
phasized the importance of comprehensive support of
the patients by healthcare providers, family and commu-
nity as a whole in increasing the treatment adherence.
This support was claimed achievable by educating family
and policymakers to increase insurance coverage for the
patients with chronic diseases and put pressure on mass
media to design programs to raise the awareness of com-
munity about diabetes, and health care providers in
terms of the effective communication with the patients.
Almost half the participants claimed that internal and
external cues may impede or facilitate the blood glucose–
lowering therapy adherence. Cues to action, which may be
considered minor, are really important for the patient
compliance and have been identified in other studies as
well [30, 31]. It is suggested that innovative and
cost-effective augment behavioral triggers such as medica-
tion reminders and challenge messages regarding the
self-management be provided for the diabetic patients.
Conclusions
Our study showed that multiple variables may affect the
medication compliance of Iranian patients with T2DM.
Some of the variables may be modified by patient educa-
tion (such as increasing people awareness regarding dia-
betes) and others are influenced by social health policies
(such as increasing insurance coverage and decreasing
anti-diabetic drug cost). Identifying these variables may
lead to the development of tailored interventions to in-
crease the regular use of medicines in patients with
T2DM. Health systems should consider medication ad-
herence training to be added to the treatment protocols
of diabetic patients.
Strength and limitation
Although this study offered a number of key themes that
could be useful in designing interventions aimed at fur-
ther enhancing the medication adherence among the pa-
tients with T2DM in Iran, it suffers from some
limitations. The first limitation was that our findings
were derived from a qualitative research design. In fact,
qualitative approach results cannot be generalized to lar-
ger populations. The second limitation was that data
were collected from a sample of patients with T2DM
who referred to the Institute of Endocrinology and
Metabolism Research and Training Center of Firooz-
gar Academic Hospital and they were likely to be
already connected to support services (e.g. education
classes, peer support, medication). Performing similar
studies in other racial/ethnic groups and geographic
areas in Iran are suggested. Also, it is suggested that
quantitative studies be performed to identify the fac-
tors influencing healthy lifestyle compliance among
the diabetic patients in Iran. Developing and evaluat-
ing the adherence-enhancing interventions for the
diabetic patients is also recommended.
Abbreviation
T2DM: Patients with Type 2 Diabetes
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